Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients

Manuscript Number: 

17-0385R1

Author(s): 
Dag Aarsland, Geir Bråthen, Ragna Espenes, Tormod Fladby, Erik Hessen, Stein Harald Johnsen, Bjørn-Eivind Kirsebom, Knut Waterloo

Disclosures

Dag Aarsland

  • Consulting Fees:
    Dr Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and serves as paid consultant for H. Lundbeck, Eisai, and Axovant. All below £1500
    Lecture Fees:
    Dr Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and serves as paid consultant for H. Lundbeck, Eisai, and Axovant. All below £1500

Geir Bråthen

  • Nothing to Disclose

Ragna Espenes

  • Nothing to Disclose

Tormod Fladby

  • Nothing to Disclose

Erik Hessen

  • Nothing to Disclose

Stein Harald Johnsen

  • Nothing to Disclose

Bjørn-Eivind Kirsebom

  • Nothing to Disclose

Knut Waterloo

  • Nothing to Disclose